In addition to the classical angiogenesis signals, studies revealed other potential pro-angiogenic targets based on cancer types, such as DGKG in HCC, BGN in gastric cancer and AEBP1 in CRC. The gene discussed is DGKG; the disease is hepatocellular carcinoma.